Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM167B divergent transcript (TMEM167B-DT) is a long non-coding RNA transcribed in the region of the TMEM167B gene. It is produced by divergent transcription—a phenomenon in which the promoter of a protein-coding gene also initiates transcription in the opposite direction, generating non-coding RNA. Such transcripts rarely encode proteins and are typically involved in local gene regulation, especially during development and cell differentiation[2][3]. Divergent transcripts often remain chromatin-associated and are co-expressed with their paired protein-coding gene. While some lncRNAs derived from divergent transcription have described regulatory roles (such as chromatin modification or influencing transcriptional pausing), TMEM167B-DT itself has not been directly tied to specific disease processes, protein interactions, or drug mechanisms. Overall, TMEM167B-DT reflects a growing understanding that many regions of the mammalian genome are pervasively transcribed, often without producing proteins, but may still contribute to complex regulatory networks influencing gene activity and epigenetic states[2][3]. In summary: TMEM167B-DT is a non-coding RNA, not a classical therapeutic target, and is best described as a divergent transcript with potential regulatory roles, but with no direct involvement in known drug interactions or disease pathways[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMEM167B divergent transcript (TMEM167B-DT).